
    
      The current study is evaluating both the efficacy and safety of the 2 doses of 500 mg
      clotrimazole vaginal tablet administered intravaginally( at day 1 and day 4) v.s 2 doses of
      150 mg fluconazole( at day 1 and day 4) for treatment of severe vulvovaginal candidiasis.The
      number of participants with adverse events as a measure of safety and tolerability.
    
  